Fig. 1

An example of the format of the clinical vignette question. In these vignettes, the study participant was first presented with a description of a child with non-systemic JIA (Juvenile Idiopathic Arthritis) (Fig. 1a). The nine patient-, disease- and treatment characteristics in the box were varied according to the experimental design. Then, the participant was asked whether they would taper the biologic in this child between 6 and 21 months after achieving clinical remission. The time in clinical remission was based on the participants own answer to an earlier question about minimal treatment time. If the participant answered negatively, they were directed to a second question (Fig. 1b) in which they were asked how long the child needs to be in clinical remission before the child is tapered. JIA = juvenile idiopathic arthritis; MTX = methotrexate; RF = rheumatoid factor; TMJ = temporomandibular joint